Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 3
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML.
Jimenez-Chillon C, Othman J, Taussig D, Jimenez-Vicente C, Martinez-Roca A, Tiong IS, Jain M, Aries J, Cakmak S, Knapper S, Kristensen DT, Murthy V, Galani JZ, Kallmeyer C, Ngu L, Veale D, Bolam S, Orfali N, Parker A, Manson C, Parker J, Erblich T, Richardson D, Mokretar K, Potter N, Overgaard UM, Roug AS, Wei AH, Esteve J, Jädersten M, Russell N, Dillon R. Jimenez-Chillon C, et al. Blood Adv. 2024 Jan 23;8(2):343-352. doi: 10.1182/bloodadvances.2023011106. Blood Adv. 2024. PMID: 38039513 Free PMC article.
Transfusion support in COVID-19 patients: Impact on hospital blood component supply during the outbreak.
Velázquez-Kennedy K, Luna A, Sánchez-Tornero A, Jiménez-Chillón C, Jiménez-Martín A, Vallés Carboneras A, Tenorio M, García García I, López-Jiménez FJ, Moreno-Jiménez G. Velázquez-Kennedy K, et al. Among authors: jimenez chillon c. Transfusion. 2021 Feb;61(2):361-367. doi: 10.1111/trf.16171. Epub 2020 Nov 4. Transfusion. 2021. PMID: 33146420
Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease.
Pérez-Lamas L, Moreno-Jiménez G, Tenorio-Núñez MC, Velázquez-Kennedy K, Jiménez-Chillón C, Astibia-Mahillo B, Núñez-Torrón C, García-Gutiérrez V, Jiménez-Martín A, Vallés-Carboneras A, López-Jiménez JF. Pérez-Lamas L, et al. Among authors: jimenez chillon c. Am J Hematol. 2021 Aug 1;96(8):E288-E291. doi: 10.1002/ajh.26214. Epub 2021 May 15. Am J Hematol. 2021. PMID: 33939851 Free PMC article. No abstract available.
The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid.
Martín-Moro F, Núnez-Torrón C, Pérez-Lamas L, Jiménez-Chillón C, Marquet-Palomanes J, López-Jiménez FJ, Herrera-Puente P. Martín-Moro F, et al. Among authors: jimenez chillon c. Leuk Res. 2021 Feb;101:106518. doi: 10.1016/j.leukres.2021.106518. Epub 2021 Jan 27. Leuk Res. 2021. PMID: 33571876 Free PMC article. No abstract available.
Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia.
Núñez-Torrón Stock C, Jiménez Chillón C, Martín Moro F, Marquet Palomanes J, Piris Villaespesa M, Roldán Santiago E, Rodríguez Martín E, Chinea Rodríguez A, García Gutiérrez V, Moreno Jiménez G, López Jiménez J, Herrera Puente P. Núñez-Torrón Stock C, et al. Among authors: jimenez chillon c. Front Oncol. 2024 May 2;14:1394648. doi: 10.3389/fonc.2024.1394648. eCollection 2024. Front Oncol. 2024. PMID: 38756667 Free PMC article.
Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.
Núñez-Torrón Stock C, Jiménez Chillón C, Martín Moro F, Marquet Palomanes J, Velázquez Kennedy K, Piris Villaespesa M, Roldán Santiago E, Rodríguez Martín E, Chinea Rodríguez A, García Gutiérrez V, Moreno Jiménez G, López Jiménez J, Herrera Puente P. Núñez-Torrón Stock C, et al. Among authors: jimenez chillon c. Hematol Oncol. 2023 Oct;41(4):753-761. doi: 10.1002/hon.3160. Epub 2023 Apr 20. Hematol Oncol. 2023. PMID: 37081742